| |
| |
|
| Insider
Information: |
Stein Jeffrey |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,157,974 |
|
|
Indirect Shares
|
380,337 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,538,311 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trius Therapeutics Inc |
TSRX |
President & CEO, Direc... |
|
0 |
2013-09-11 |
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
President & CEO, Direc... |
2024-03-11 |
1,153,693 |
2024-03-11 |
373,611 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2023-09-21 |
0 |
2017-02-02 |
0 |
Premium* |
|
|
Ideaya Biosciences, Inc. |
IDYA |
Director |
2019-05-22 |
4,281 |
2019-05-22 |
6,726 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSRX |
Trius Therapeutics Inc |
President and CEOOfficer |
• • – |
2010-08-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
144,010 |
|
- |
|
| TSRX |
Trius Therapeutics Inc |
President and CEO |
• • – |
2010-08-06 |
4 |
A |
$0.00 |
$0 |
I/I |
5,285 |
149,295 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
President and CEO |
• • – |
2010-12-15 |
4 |
OE |
$0.52 |
$11,804 |
I/I |
22,700 |
171,995 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
President and CEO |
• • – |
2012-03-27 |
4 |
OE |
$0.52 |
$20,000 |
I/I |
38,462 |
210,457 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
President & CEO |
• • – |
2013-09-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(210,457) |
0 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEOOfficer |
• • – |
2015-04-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
199,387 |
|
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2015-04-20 |
4 |
B |
$16.00 |
$6,720 |
I/I |
420 |
420 |
2.58 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2015-11-24 |
4 |
B |
$14.97 |
$80,838 |
D/D |
5,400 |
5,400 |
2.81 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2015-11-25 |
4 |
B |
$15.60 |
$20,280 |
D/D |
1,300 |
6,700 |
2.81 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2016-05-20 |
4 |
B |
$11.51 |
$49,608 |
I/I |
4,310 |
203,697 |
2.66 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2017-03-31 |
4 |
B |
$7.75 |
$99,975 |
D/D |
12,900 |
27,196 |
2.81 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2017-06-05 |
4 |
B |
$5.95 |
$89,211 |
D/D |
15,000 |
44,501 |
2.81 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2017-09-12 |
4 |
B |
$6.79 |
$49,907 |
D/D |
7,350 |
51,851 |
2.81 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
13,500 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2018-05-23 |
4 |
B |
$4.70 |
$1,000,000 |
D/D |
212,766 |
268,320 |
2.81 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2018-11-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,619 |
5,039 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2018-11-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
9,238 |
194,459 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2019-02-15 |
4 |
AS |
$7.14 |
$24,098 |
D/D |
(3,375) |
10,125 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
17,625 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2019-02-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
21,340 |
173,119 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2019-02-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,670 |
15,709 |
0 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
Director |
– • – |
2019-05-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,726 |
|
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
Director |
– • – |
2019-05-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,281 |
|
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
President & CEO |
• • – |
2019-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
282,320 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
